Skip to main content
. 2012 Feb 13;2012:910698. doi: 10.1155/2012/910698

Table 2.

Characteristics of the pre-chemotherapy patients who had ovarian tissue cryopreservation.

No. Pathology Age (months) D/mm2 (RO) D/mm2  (LO) Cryopreserved fragments No.
1 Wilms tumor 53 49.89 63
2 Shwachmann syndrome 118 58.83 24.05 10
3 Ewing sarcoma 78 36.92 39.04 10
4 Ewing sarcoma 120 64.02 102.77 15
5 Hodgkin lymphoma 161 11.51 16.53 23
6 Hodgkin lymphoma 177 31.8 13.59 44
7 Hodgkin lymphoma 182 11.26 1.00 14
8 Hodgkin lymphoma 195 90.80 44.28 10
9 Non-Hodgkin lymphoma 205 1.92 1.74 9
10 Hodgkin lymphoma 206 12.18 15.64 14
11 Ewing sarcoma 144 159.24 26.30 11
12 Ewing sarcoma 173 0.69 1.58 16
13 Ewing sarcoma 184 18.41 15.45 23
14 Ewing sarcoma 190 3.20 11.84 21
15 Bone marrow aplasia 152 14.68 15.12 45
16 Bone marrow aplasia 160 14.47 10.37 38
17 Myelodisplasia 152 4.07 11.26 17
18 Mixoide tumor 203 15.47 8.01 16
19 Thalassemia major 180 9.98 17.80 22
20 Thalassemia major 193 2.58 6.96 33
21 Hodgkin lymphoma 214 18.24 13.87 12
22 Systemic lupus Erythematosus 198 1.87 1.66 33

No. 1–4 premenarcheal patients, No. 5–22 postmenarcheal patients.

D/mm2: follicle density per mm2.

RO: right ovary; LO: left ovary.